TP53 and diffuse large B-cell lymphoma: Our results showed that P53 signaling pathway was significantly downregulated in PBL compared to GCB-DLBCL, indicating that inactivated P53 may contribute to lymphomagenesis in PBL and serve as a potential therapeutic target in the future.